In the field of molecular biology and protein characterization, the 2f1 rep1 human peptide 12 May 2016—Eponemycin and its analog are one of naturalpeptidein epoxyketonegroup which is used in this research. Until date,peptideα'β Read more sequence serves as a critical reference point for researchers analyzing the Rab Escort Protein 1 (REP-1). As someone who closely follows advancements in peptide science and immunological research, I find the specificity of the 2F1 monoclonal antibody to be a fa Sequencecoverage: Thesequencecoverage can be expanded with a simple mouse-click to display all identified distinctpeptide sequences. Domain structure Read more scinating example of how targeted tools allow us to gain insights into complex protein structures.
The Significance of the 2F1 Antibody in REP-1 Analysis
The 2F1 antibody is widely recognized in scientific literature for its high specificity in recognizing the C-terminus of the human REP-1 protein. When evaluating protein expression or conducting immunoblot analysis, the Anti-REP-1 Antibody, clone 2F1, is often the gold standard for verifying the presence of the protein.
From my perspective reviewing laboratory standards, the ability to confirm the identity of human REP1 via a specific sequence is essential. The REP-1 sequence ends at N442, followed by the distinct peptide VLTCAIQADLQGSADYRI at the C-terminus. This specific amino acid sequence is what the 2F1 antibody targets, providing a reliable way to differentiate between wild-type and truncated or mutated forms of the protein.
Structural Insights and Peptide Research
When we discuss the human sequence of such proteins, we are looking at the foundational architecture of biological function. The REP-1 protein, encoded by the CHM gene, is vital for prenylation processes. Because the human and rat forms of Rep-1 (or rep-1) show high homology, researchers often rely on these structural similarities to model the effects of variants.
In my exploration of peptide sequences, I have observed that the precision of tools like the REP-1 (2F1): m-IgG Fc BP-HRP Bundle allows for consistent sequence detection across v 22 Sept 2009—This entry describes 2 isoforms produced by Alternative splicing. P24903-1. This isoform has been chosen as the canonicalsequence. All Read more arious experimental setups. Whether you are performing Western blots or other immunological assays, the robustness of the 2F1 clone ensures that the human REP1 protein is accurately identified.
Key Considerations for Research Applications
While investigating peptide structures, it is important to understand the broader context of the FPR1 gene and other related proteins that share similar structural motifs. The human sequences utilized in studies—often sourced from databases like Proteomics DB—are the benchmarks that allow us to understand how subtle changes in a protein can affect its overall conformation.
For those interested in the technical aspects of REP1 sequence analysis, here are a few observations from the literature:
* Specificity: The 2F1 antibody is specifically designed to recognize the C-terminal epitope.
* Verification: Using high-fidelity antibodies is crucial when verifying the results of gene augmentation or other experimental interventions.
* Data Integrity: Reliable peptide sequences are the backbone of reproducible research. Always ensure that the Human protein variants are clearly categorized, especially when dealing with missense mutations or alternative isoforms.
Final Reflections
Navigating the complexities of the 2f1 rep1 human peptide sequence requires a deep appreciation for the precision of biological tools. By focusing on the specific amino acid sequence and utiliz Proteomics DB ing well-validated tools like the 2F1 clone, researchers can achieve a cleare 28 Mar 2026—Abstract. 30. CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene.Read more r pi Analysis of eponemycin (a'ß' epoxyketone) analog cture of protein identity and functional integrity. My experience in this niche confirms that the intersection of high-quality peptide characterization and standardized antibodies remains the most reliable path for those seeking to understand the architectural nuances of the REP-1 protein.
Whether you are looking at the canonical human sequence or analyzing the impact of specific mutations, the integr RU2762747C2 - Gene therapy of ophthalmic disorders ation of structural data with robust antibody-based detection remains an indispensable practice in modern laboratory settings.